Drug intelligence / Profile preview

R43

Development stage: Unknown
Lead developer: PHD Biosciences
Modality: Nanoparticles → Drug Delivery Systems
Administration: Topical

Overview

R43 is a component of a sunscreen product, described as long-wear metal oxide particles. It is being studied for its water resistance properties and Sun Protection Factor (SPF) according to regulatory standards for sunscreen drug products. Developed by Nanometics (d.b.a. PHD Biosciences), its primary function is to provide sun protection by physically blocking and scattering ultraviolet (UV) radiation.

Other names: Sunscreen -R43

Beyond the preview

Go deeper on R43.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on R43.

Explore the full profile